ERYTHROMYCIN, A MACROLIDE ANTIBIOTIC, HAS BEEN USED widely in pediatrics to treat a number of infections. Initially given as an alternative to penicillin because of that drug's potential for allergic reactions, erythromycin was first introduced in 1952.1 Erythromycin is currently used in neonatal settings for treatment of infections caused by Chlamydia, Ureaplasma, and Mycoplasma.1,2 Prophylaxis for ophthalmia neonatorum and treatment of otitis media are often managed with erythromycin. Erythromycin is the only drug currently proven effective for both prophylaxis and treatment of Bordetella pertussis (not a common pathogen in neonatal intensive care units, however).
Document Type: Research Article
Publication date: September 1, 1999
- Neonatal Network is no longer available to subscribers on Ingenta Connect. Please go to http://connect.springerpub.com/content/sgrnn to access your online subscription to Neonatal Network.